Moreover, later work identified S100a9 as a downstream target of Setd2-deficient myelodysplasia and was associated with accelerated leukemia transformation in the murine NHD13 MDS model though direct involvement of the niche has not been demonstrated [39]. The gene discussed is S100A9; the disease is myelodysplastic syndrome.